Published in Magn Reson Med on August 01, 1996
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev (2009) 2.52
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol (2012) 1.38
A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals. Magn Reson Med (2011) 1.18
Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol (2006) 1.15
Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol (2010) 1.12
A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer (2006) 1.12
Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med (2009) 0.97
Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics (2012) 0.94
Vascular characterisation of triple negative breast carcinomas using dynamic MRI. Eur Radiol (2011) 0.90
Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging. Eur J Nucl Med Mol Imaging (2014) 0.88
Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging. Eur J Nucl Med Mol Imaging (2012) 0.88
Cardiovascular magnetic resonance physics for clinicians: Part II. J Cardiovasc Magn Reson (2012) 0.86
Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging. Br J Cancer (2001) 0.85
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. Br J Cancer (2008) 0.83
Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging (2015) 0.81
DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS One (2014) 0.80
Spatiotemporal quantification of local drug delivery using MRI. Comput Math Methods Med (2013) 0.80
The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol (2015) 0.80
Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters. Medicine (Baltimore) (2015) 0.79
A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study. Magn Reson Med (2009) 0.78
Noninvasive methods to study drug distribution. Invest New Drugs (2003) 0.78
Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc Diagn Ther (2014) 0.78
The principal of dynamic contrast enhanced MRI, the method of pharmacokinetic analysis, and its application in the head and neck region. Int J Dent (2012) 0.77
Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement. Magn Reson Med (2013) 0.77
The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data. Magn Reson Imaging (2014) 0.76
Investigation into diagnostic accuracy of common strategies for automated perfusion motion correction. J Med Imaging (Bellingham) (2016) 0.75
Arterial input functions in dynamic contrast-enhanced magnetic resonance imaging: which model performs best when assessing breast cancer response? Br J Radiol (2016) 0.75
Utilization of MR angiography in perfusion imaging for identifying arterial input function. MAGMA (2017) 0.75
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26
Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet (2000) 2.97
Fiber crossing in human brain depicted with diffusion tensor MR imaging. Radiology (2000) 2.72
Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging (1994) 2.27
Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. Int J Cardiol (2012) 2.08
Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn Reson Med (1999) 2.06
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
Feature-space clustering for fMRI meta-analysis. Hum Brain Mapp (2001) 1.88
On clustering fMRI time series. Neuroimage (1999) 1.80
Epidemiology of sprains in the lateral ankle and foot. Foot Ankle Int (1994) 1.73
Elongation factor 2. Amino acid sequence at the site of adenosine diphosphate ribosylation. J Biol Chem (1974) 1.70
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage (2000) 1.64
Generalizable patterns in neuroimaging: how many principal components? Neuroimage (1999) 1.61
Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke (2002) 1.50
Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol (1996) 1.43
31P magnetic resonance spectroscopy of skeletal muscle in patients with fibromyalgia. J Rheumatol (1992) 1.41
Cerebral cortex thickness in 15-year-old adolescents with low birth weight measured by an automated MRI-based method. Brain (2005) 1.40
A controlled comparison of myelography, computed tomography, and magnetic resonance imaging in clinically suspected lumbar disc herniation. Spine (Phila Pa 1976) (1995) 1.40
Effects of recombinant human erythropoietin on the haemopoietic bone marrow monitored by magnetic resonance spectroscopy in patients with end-stage renal disease. Magn Reson Imaging (1990) 1.39
Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart (2001) 1.38
[Volumes of synovial membrane and joint effusion determined by MR imaging. Markers of severity and/or activity in rheumatoid arthritis?]. Ugeskr Laeger (1997) 1.38
Mental illness in new neurological patients. J Neurol Neurosurg Psychiatry (2003) 1.36
Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba). Acta Neurol Scand (1970) 1.35
Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry (2005) 1.32
Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol (2000) 1.30
In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging (1993) 1.28
Visual activation in infants and young children studied by functional magnetic resonance imaging. Pediatr Res (1998) 1.27
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
Local sympathetic reflex mechanism in regulation of blood flow in human subcutaneous adipose tissue. Acta Physiol Scand Suppl (1977) 1.20
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia (1996) 1.16
Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry (1998) 1.15
Homology between the mammalian liver and the Drosophila fat body. Trends Genet (1993) 1.13
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia (1996) 1.13
Functional MRI of CO2 induced increase in cerebral perfusion. NMR Biomed (1994) 1.12
Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants. J Biol Chem (2000) 1.11
Ultrasonography in arthritis of the knee. A comparison with MR imaging. Acta Radiol (1995) 1.10
Molecular cloning, genomic organization and developmental regulation of a novel receptor from Drosophila melanogaster structurally related to gonadotropin-releasing hormone receptors for vertebrates. Biochem Biophys Res Commun (1998) 1.09
Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn Reson Imaging (1992) 1.09
In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med (1988) 1.08
Long distance running and osteoarthrosis. Am J Sports Med (1990) 1.07
Myocardial perfusion modeling using MRI. Magn Reson Med (1996) 1.07
Local reflex in microcirculation in human skeletal muscle. Acta Physiol Scand (1977) 1.07
[Hudegården and its underground clinic]. Ugeskr Laeger (1970) 1.06
Functional magnetic resonance imaging of the normal and abnormal visual system in early life. Neuropediatrics (2000) 1.05
Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J (1993) 1.04
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Scoring of synovial membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol (1995) 1.04
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04
Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed (1994) 1.03
The effects of refractory epilepsy on intellectual functioning in children and adults. A longitudinal study. Seizure (2001) 1.03
Local nervous mechanism in regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand (1976) 1.03
Molecular cloning, genomic organization, developmental regulation, and a knock-out mutant of a novel leu-rich repeats-containing G protein-coupled receptor (DLGR-2) from Drosophila melanogaster. Genome Res (2000) 1.02
Activity of polyadenosine diphosphoribose polymerase during the human cell cycle. Biochem Biophys Res Commun (1971) 1.01
Texture analysis in quantitative MR imaging. Tissue characterisation of normal brain and intracranial tumours at 1.5 T. Acta Radiol (1995) 1.01
Quantitative assessment of synovial inflammation by dynamic gadolinium-enhanced magnetic resonance imaging. A study of the effect of intra-articular methylprednisolone on the rate of early synovial enhancement. Br J Rheumatol (1996) 1.01
In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging (1992) 1.01
Quantification of complex flow using MR phase imaging--a study of parameters influencing the phase/velocity relation. Magn Reson Imaging (1992) 1.01
Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol (1994) 0.99
Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison. J Cereb Blood Flow Metab (2000) 0.99
Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: II. Normal values and gray matter blood flow response to visual activation. J Cereb Blood Flow Metab (2000) 0.99
The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging (1993) 0.98
Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med (1998) 0.98
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
Comparison between retrospective gating and ECG triggering in magnetic resonance velocity mapping. Magn Reson Imaging (1993) 0.97
A simple calf muscle ergometer for use in a standard whole-body MR scanner. Magn Reson Med (1990) 0.96
Monoaminergic systems in the brainstem and spinal cord of the turtle Pseudemys scripta elegans as revealed by antibodies against serotonin and tyrosine hydroxylase. J Comp Neurol (1992) 0.96
Signal changes in gradient echo images of human brain induced by hypo- and hyperoxia. NMR Biomed (1995) 0.96
White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry (1994) 0.96
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Visual cortex reactivity in sedated children examined with perfusion MRI (FAIR). Magn Reson Imaging (2002) 0.96
Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail (2001) 0.95
Evaluation of right ventricular volumes measured by magnetic resonance imaging. Eur Heart J (1988) 0.95
Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging (2009) 0.95
Effect of "vein pump" activation upon venous pressure and blood flow in human subcutaneous tissue. Acta Physiol Scand (1977) 0.94
Purification and chemical characterization of papain-solubilized histocompatibility-2 antigens from mouse liver. J Biol Chem (1979) 0.94